API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.fiercepharma.com/pharma/koreas-antitrust-watchdog-slaps-astrazeneca-small-fine-over-plot-stall-generic-lucrative
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.in-pharmatechnologist.com/Article/2019/03/26/AstraZeneca-cuts-94-jobs-from-UK-campus
https://www.biopharmadive.com/news/astrazeneca-sell-off-deal-covis-respiratory/541614/
https://www.bloomberg.com/news/articles/2017-09-05/astrazeneca-chief-soriot-says-he-s-worried-about-brexit-talks
https://www.themanufacturer.com/articles/astrazeneca-invest-150m-in-new-facility/
http://www.in-pharmatechnologist.com/Drug-Delivery/AZ-confirms-Macclesfield-investment-but-says-Brexit-strategy-unchanged
http://www.pharmafile.com/news/513355/astrazeneca-sells-cancer-drug-tersera-250-million
http://www.fiercepharma.com/manufacturing/astrazeneca-opens-cancer-med-plant-u-k
http://cphi-online.com/alvogen-launches-first-generic-equivalent-of-news040490.html